OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

for the year ended
Contents
31 March 2021
Trustee's
Report
3
Statement ofTrustee's responsibilities. .13
Independent
Auditor's
Report. .14
Statement of Financial Activities. .1S
Balance Sheet. .19
Statement ofCash Flows 20
Notes to the accounts 21

2021 2020
Unrestricted Restricted Total Unrestricted Restricted Total
Note Funds Funds Funds Funds
g000 K'000 8000 K'000 E'000 6000
income from:
Donations 312 97 409 482
Legacies 335 263 598 9
Grants 178 178
647 538 1,185 491 2 493'
Investments 26 6 32 48 6 54
Tots I income 673 544 1,217 539 8 547
Expenditure
on:
Raising funds:
Other trading costs (3) (3) (44) (44)
Investrpent
management
costs (5) (1) (8)
Charitable
activities
4 (1,639) (514) (2,153) (975) (27) (1,002)
Total expenditure (1,642) (514) (2,156) (1,024) (28) (1,052)
Gains on investments 724 (18) 21
Net movement in funds (311) 96 (215) (503) 1 (502)
Fund balances brought forward 3,571 546 4,117 4,074 545 4,619
Fund balances carried forward 3,260 642 3,902 3,571 546 4,117

Balance She et as at 31 March 202 1
Note 2021 2020
R'000 f'000 f'000 6000
Fixed Assets
Investments 3,497 3,440
3,497 3,440
Current Assets
Debtors 323 9
Cash at Bank and in Hand 768 1,445
1,091 1,454
Creditors: Amounts Falling Due Within One Year (686) P?7)
Net Current Assets 405 677
Total Assets Less Current Liabilities 3,902 4,11?
Tota I Net Assets 3,902 4,117
Funds ofthe Charity
Restricted
Income Funds
10 642 546
Designated
Income Funds
10 3,174 3,529
General
income Funds
10 86 42
Total Charity Funds 3,902 4,117

2021 2020
Notes f.'000 F000
Cash inflow from operating
activities:
Net cash provided
by (used in) operating
activities A (1,376) (70)
Cash inflow from investing
activities:
Dividends and interest
from investments
32 54
Proceeds from the disposal of investments 751 793
Purchase ofinvestments (84) (87)
Net cash provided
by (used in) investing
activities 699 760
Change in cash and cash equivalents in the year (677) 690
Cash and cash equivalents
at 1 April 2020
1,445 755
Cash and cash equivalents
at 31 March
2021 768 1,445
A Reconciliation
ofnet movement
in funds in funds to net cash flow from operating activities
2021 2020
8'000 F'000
Net movement
in funds {asper the
statement offinancial activities) (215) (502)
Adjustments
for:
(Gains) losses on investments (724) (3)
Dividends
and interest from investments
(32) (54)
(Increase) decrease
in debtors
(314) 306
Increase (decrease)
in creditors
(91) 183
Net cash provided
by.(used in) operating
activities {1,376) {70)
B Analysis of cash and cash equivalents
2020 2020
E'000 R'000
Cash at bank and in hand 268 1,445
Cash held by investment
managers
500
Total cash and cash equivalents 768 1,446

2. Analysis ofDon ations, Legacies a nd Grants
2021 2020
Unrestricted Restricted Total Unrestricted Restricted Total
Funds Funds Funds Funds
R'000 K'000 R'000 K'000 K'000 8000
Donations 312 97 409 482 2 484
Legacies 335 263 598 9 9
Grants receivable 178 178
647 538 1,185 491 2 493
2021 2020
Unrestricted Restricted Total Unrestricted Restricted Total
Funds Funds Funds Funds
F'000 F'000 R'000 K'000 K'000 E'000
NHSCT stage 1 grant 1stpayment 32 32
NHSCT stage 1 grant 2nd payment 46 46
NHSCT BAME grant 50 50
NHSCT second wave funding 50 50
178 178

3. Allocatio n ofSupport Costs and Overheads
2021 ' 2020
Total Total
8000 R'000
Accountancy support 49 48
External audit 9 12
Bank charges 1 2
Software maintenance 3 4
62 66

The table below shows the categories of programmes below shows the categories of programmes below shows the categories of programmes that the Charity has supported that the Charity has supported that the Charity has supported during
the financial year under review.
2021 2020
Unrestricted Restricted Total Unrestricted Restricted Total
Funds Funds Funds Funds
f'000 R'000 E'000 f,'000 2000 K'000
'Patients' welfare and amenities 39 52 91 205 205
Staff welfare and education 54 170 224 113 118
Purchase ofclinical equipment 458 458 148 15 163
Enhancing patient environment 998 281 1,279 409 409
Patient education 1 1
Research 39 39 40 40
Support costs 51 62 59 66
1,639 514 2,153 975 27 1,002

31 March 31 March
2021 2020
6'000 K'000
Listed Investments
Market value at 1 April 3,440 4,143
Additions
to investments
at cost 84 87
Disposals at book value (751) (720)
Net Unrealised
investment
gains/(losses) 724 (7o)
Market value at 31 March 3,497 3,440
Cash held by investment managers for re-investment
Carrying
value at 31 March
3;497 3,440
Historic cost of investments at 31 March 2,854 2,727
nvestments
held at 31
INarch comprise d the following:
31 March 31March
2021 2020
K'000 K'000
UK common investment funds 1,042 825
Overseas hedge funds 2,455 2,615
3,497 3,440

7. Total Gr oss Incom e from I nvestments
Unrestricted Restricted 2021
Funds Funds Total
K'000 f.'000 f,'000
Return on investments held:
UK common investment funds 25 31
Overseas hedge funds
Bank interest
26 32
Unrestricted Restricted 2020
Funds Funds Total
6'000 K'000 Z'000
Return on investments held:
UK common investment funds 27 4 31
Overseas hedge funds 14 2 16
Bank interest ? 7
48

Debtors
31Ilarch 31 March
2021 2020
F'000 f'000
Amounts
falling due within one year:
Prepayments and accrued income 314
Other debtors 9
Total debtors 323

Cash at Bank and in Han d
31 31
INarch INarch
2021 2020
6000 K'000
Cash at bank and in hand 766 1,445
Cash in hand represented petty cash ofF200 (2020 -8200).

Creditors
31 March 31March
2021 2020
8000 f'000
Amounts falling due within one year:
Amounts due to related parties 191 3
Other creditors 3 2
Grants payable 483 760
Accruals 9 12
686 777

Balance at Balance at
1 April Gains and 31INarch
2020 Income Expenditure Losses 2021
E'000 E'000 F000 f'000 R'000
Restricted
Stroke Services Development Charitable Fund RHCH 24 267 (67) 9 233
Winchester
Hospice Fund
263 2 (283) 18
RHCH Staff Benefit 178 7 (3) 18 200
Arthritis
Research - Legacy
I H Spain 81 1 (2) 8 88
Covid-19 217 (150) 10 77
BAME StaffSupport 50 (9) 3
RHCH Patient Benefit
Total restricted funds (514)
Unrestricted
Designated
funds
Magic Wand Appeal 52 (12) 5 46
Orthopaedic
Department
General Purposes 480 14 46 544
RHCH Chapel 125 (6) 11 132
Pseudomyxoma/Colorectal Research 173 47 (31) 16 205
Clinical Haematology 71 (51) 6 2?
Liver Fund 157 (14) 16 163
Oncology
Unit (Previously
EH Unit orWessex) 146 84 (25) 17 222
Ward C2 51 (1) . 6 60
Cardiology
Education
Fund 99 (4) 10 106
Paediatric Wards
NHH
77 (37) 8 51
Coronary
Care Unit
71 (5) 7 75
Winchester
Medical Foundation
Charitable Fund 317 (275) 22 64
Winchester Hospice Fund 77? 152 (902) 31 58
Other designated 933 125 (83) 446 1,421
Total designated
funds
3,529 430 (1,432) 3,174
General Funds 42 243 (210) 86
Total unrestricted
funds
3,571 673 (1,642) 3,260
Total Funds 4,117 1,217 (2,156) 724 3,902

Balance at Balance at
1 April Gains and 31 Nlarch
2019 Income Expenditure Losses 2020
f 000 F000 6000 F000 R'000
Restricted
Stroke Services Development Charitable Fund RHCH 31 (9) 24
Winchester
Hospice
Fund 250 (4) 14 263
RHCH Staff Benefit 177 (6) 178
Arthritis
Research -
Legacy I H Spain 79 (1) 81
RHCH Patient Benefit 8 (8)
Total restricted funds (28) 21
Unrestricted
Designated
funds
Magic Wand Appeal 71 (23) 52
Orthopaedic
Department
General Purposes 524 (64) 13 480
RHCH Chapel 136 3 (16) 2 125
Pseudomyxoma/Coiorectal Research 156 25 {12) 4 173
Clinical Haematology 87 21 (39) 2 71
Liver Fund 178 21 (47) 5 157
Oncology
Unit (Previously
EH Unit or Wessex) 133 17 (9) 5 146
Ward C2 31 22 (3) 1 51
Cardiology
Education
Fund 130 2 {36) 3 99
Paediatric Wards
NHH
91 8 (24) 2 77
Coronary
Care Unit
75 3 {9) 2 71
Winchester
Medical
Foundation
Charitable
Fund 654 21 (375) 17 317
Winchester Hospice Fund 615 196 (54) 20 777
Other designated 1,131 175 (276) (97) 933
Total designated
funds
4,012 523 (987) (19) 3,529
General Funds 62 16 {37) 42
Total unrestricted funds 4,074 539 (1,024) (18) 3,571
Total Funds 4,619 547 (1,052) 4,117

Fund balan ces as at 31 INarch 20 21 are rep resented
by:
General Restricted 2021 General Restricted 2020
Funds Funds Total Funds Funds Total
f.'000 f'000 f'000 f'000 f'000 R'000
Investments 3,337 160 3,497 3,073 367 3,440
Current Assets 350 741 1,091 1,242 212 1,454
Creditors: Amounts falling due within one year (427) (259) (686 (744) (33) (777)
3,260 642 3,902 3,571 546 4,117